LIGAND PHARMACEUTICALS INCORPORATED Convertible Debt, Current
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Convertible Debt, Current of $0 as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:ConvertibleDebtCurrent · last filed 2024-02-29
- 2023-12-31: Convertible Debt, Current $0.00.
- 2023-09-30: Convertible Debt, Current $0.00.
- 2023-06-30: Convertible Debt, Current $0.00.
- 2023-03-31: Convertible Debt, Current $76.79M.
| Period end | Convertible Debt, Current | Convertible Debt, Current as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $76.79M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $76.69M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $76.60M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $114.97M 10-Q · filed 2022-08-09 | |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 | |
| 2019-12-31 | $0.00 10-K · filed 2020-02-27 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $27.09M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $26.76M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $26.43M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $213.14M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $210.37M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $227.55M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $224.53M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $221.56M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $218.63M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $215.75M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $212.91M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $210.12M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $207.36M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $201.99M 10-K · filed 2017-02-28 | $0.00 10-Q · filed 2016-08-04 |